VectivBio Holding AG
VECTNASDAQHealthcare
$16.87
+$0.02(+0.12%)
Market Cap$1.1B
P/E Ratio—
52W High$16.98
52W Low$4.25
VectivBio Holding AG (VECT) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
VECT · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2022Report Date: Dec 31, 2022EPS Actual
-$0.65
Revenue
$0.00B
Fiscal Period
Q4 FY2022
FY ends December
Report Date
Dec 31, 2022
After Market Close
VECT reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2023 | Apr 19, 2023 | -$0.52 | — | — | — | — | — |
| — Q4 FY2022 | Dec 31, 2022 | — | -$0.65 | — | $0.00B | — | — |
| ▼ Q3 FY2022 | Jul 7, 2022 | -$0.64 | -$1.48 | -131.1% | $0.03B | — | — |
| ◌ Q2 FY2022 | Apr 7, 2022 | -$0.61 | — | — | — | — | — |
| — Q4 FY2021 | Dec 31, 2021 | — | -$1.61 | — | — | — | — |
| ◌ Q4 FY2021 | Oct 29, 2021 | -$0.57 | — | — | — | — | — |
| — Q2 FY2021 | Jun 30, 2021 | — | -$1.61 | — | — | — | — |
| ◌ Q2 FY2021 | Apr 9, 2021 | — | — | — | — | — | — |
Q2 FY2023
Apr 19, 2023
EPS Actual
—
EPS Est.
-$0.52
EPS Surpr.
—
Revenue
—
Q4 FY2022
Dec 31, 2022
EPS Actual
-$0.65
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2022
Jul 7, 2022Miss
EPS Actual
-$1.48
EPS Est.
-$0.64
EPS Surpr.
-131.1%
Revenue
$0.03B
Q2 FY2022
Apr 7, 2022
EPS Actual
—
EPS Est.
-$0.61
EPS Surpr.
—
Revenue
—
Q4 FY2021
Dec 31, 2021
EPS Actual
-$1.61
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2021
Oct 29, 2021
EPS Actual
—
EPS Est.
-$0.57
EPS Surpr.
—
Revenue
—
Q2 FY2021
Jun 30, 2021
EPS Actual
-$1.61
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2021
Apr 9, 2021
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
No analyst estimates available for VECT.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q4 FY2022 | Dec 31, 2022 | — | $8.67 | $8.76 | +1.10% |
| ▼ Q3 FY2022 | Jul 7, 2022 | -131.1% | $5.96 | $5.89 | -1.10% |
| — Q4 FY2021 | Dec 31, 2021 | — | $5.04 | $4.91 | -2.58% |
| — Q2 FY2021 | Jun 30, 2021 | — | $12.01 | $11.66 | -2.91% |
| — Q4 FY2020 | Dec 31, 2020 | — | No price data | $17.00 | — |
| — Q2 FY2020 | Jun 30, 2020 | — | No price data | $17.00 | — |
| — Q4 FY2019 | Dec 31, 2019 | — | No price data | $17.00 | — |
| — Q2 FY2019 | Jun 30, 2019 | — | No price data | $17.00 | — |
Q4 FY2022+1.10%
Report Date
Dec 31, 2022
EPS Beat/Miss
—
Price Before
$8.67
Price After
$8.76
Q3 FY2022-1.10%
Report Date
Jul 7, 2022
EPS Beat/Miss
-131.1%
Price Before
$5.96
Price After
$5.89
Q4 FY2021-2.58%
Report Date
Dec 31, 2021
EPS Beat/Miss
—
Price Before
$5.04
Price After
$4.91
Q2 FY2021-2.91%
Report Date
Jun 30, 2021
EPS Beat/Miss
—
Price Before
$12.01
Price After
$11.66
Q4 FY2020—
Report Date
Dec 31, 2020
EPS Beat/Miss
—
Price Before
—
Price After
$17.00
Q2 FY2020—
Report Date
Jun 30, 2020
EPS Beat/Miss
—
Price Before
—
Price After
$17.00
Q4 FY2019—
Report Date
Dec 31, 2019
EPS Beat/Miss
—
Price Before
—
Price After
$17.00
Q2 FY2019—
Report Date
Jun 30, 2019
EPS Beat/Miss
—
Price Before
—
Price After
$17.00
Avg Miss Reaction-1.10%
Beat Rate0 / 8 quarters
Largest Move-2.91% (Q2 FY2021)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: VECT ends December
VectivBio Holding AG (VECT) most recently reported earnings on December 31, 2022 for Q4 FY2022, posting EPS of $-0.65 (in line with the analyst consensus of —). The next VECT earnings date is expected around September 1, 2026.
Each quarter, investors track VECT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. VECT revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
VECT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
VECT earnings · 4 questionsVectivBio Holding AG's next earnings report is expected around September 1, 2026. VECT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; VECT historically reports after market close (AMC).
VECT earnings datewhen is VECT earningsVECT next earnings datewhen does VECT report earningsVECT earnings calendar
▸ Source: FMP · VectivBio Holding AG SEC filings · US GAAP · VectivBio Holding AG SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026